Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Treasury Shares (2021 - 2025)

Oncology Institute's Treasury Shares history spans 3 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Treasury Shares changed 0.0% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, changed 0.0%, while the annual FY2025 figure was $1.0 million, 0.0% changed from the prior year.
  • Treasury Shares reached $1.7 million in Q4 2025 per TOI's latest filing, roughly flat from $1.7 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.6 million in Q1 2023 to a low of $1.4 million in Q2 2021.
  • Average Treasury Shares over 5 years is $1.9 million, with a median of $1.7 million recorded in 2024.
  • The largest YoY upside for Treasury Shares was 13.98% in 2024 against a maximum downside of 0.0% in 2024.
  • A 3-year view of Treasury Shares shows it stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Treasury Shares are $1.0 million (Q4 2025), $1.0 million (Q3 2025), and $1.0 million (Q2 2025).